Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Gut and Liver
>
2017
>
11
>
3
Volume:
11
Issue:
3
1. Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.
Page:447—447
2. Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction.
Page:440—446
3. The Role of Endoscopic Biliary Drainage without Sphincterotomy in Gallstone Patients with Cholangitis and Suspected Common Bile Duct Stones Not Detected by Cholangiogram or Intraductal Ultrasonography.
Page:434—439
4. Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea.
Page:426—433
5. Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients.
Page:417—425
6. Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma.
Page:409—416
7. Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B.
Page:401—408
8. Expression of MicroRNA in Host Cells Infected with Helicobacter pylori.
Page:392—400
9. Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan.
Page:383—391
10. Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus.
Page:377—382
11. Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life.
Page:370—376
12. Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease.
Page:363—369
13. Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?.
Page:358—362
14. Functional Dyspepsia: Advances in Diagnosis and Therapy.
Page:349—357
15. Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis.
Page:335—348
16. Obesity-Related Digestive Diseases and Their Pathophysiology.
Page:323—334
17. Can Magnetic Resonance Elastography Fill a Niche in the Market for Noninvasive Assessment of Liver Fibrosis?.
Page:321—322
18. Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease.
Page:319—320
19. Micronutrients Should Be Monitored in the Real Practice for Korean Inflammatory Bowel Disease Patients.
Page:317—318
20. Clinical Considerations of Silent Gastroesophageal Reflux Disease in Morbidly Obese Patients.
Page:315—316